Biodesix, Inc. (BDSX) Issuance Of Sixth Amendment Warrants — Quarterly & Annual

Screener

Issuance Of Sixth Amendment Warrants at other companies

NextNavNN

-$2.25M—

NextNavNN

-$2.25M—

Taysha Gene Therapies, Inc.TSHA

$409.25K—

KEE

Keel InfrastructureKEEL

$11.48M—

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

Ispire Technology Inc.ISPR

$91.49K—

Other financials

Income statement

Revenue$26.9M+34.2%

Operating income-$5.4M+44.6%

Net income-$7.3M+36.6%

EPS (diluted)-$0.71+54.5%

Balance sheet

Cash & equivalents$30.0M+44.7%

Total debt$71.8M-0.5%

Total equity$9.1M+704%

Total assets$95.3M+8.6%

Cash flow

Operating cash flow-$1.6M+76.2%

CapEx$197.0K+286%

Free cash flow-$1.8M+73.4%

Valuation

Market cap$235.91M+313%

Enterprise value$277.71M+156%

P/S2.3×+1.5×

Profitability

Operating margin-20%-7.1pp

Net margin-27%-9.0pp

FCF margin-20.3%-6.8pp

Returns & leverage

Return on equity-540%-1,719pp

Debt / equity7.9×-55.5×

Current ratio2.8×+0.7×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept bdsx:IssuanceOfSixthAmendmentWarrants.

The source filing: Biodesix, Inc.’s 10-Q, filed May 4, 2026. Open the filing →

Filed: May 4, 2026, 4:05 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001193125-26-203960

FAQ

What is Biodesix, Inc.'s issuance of sixth amendment warrants?: Biodesix, Inc. (BDSX) reported issuance of sixth amendment warrants of $1.25M in Q1 2026.
What does issuance of sixth amendment warrants mean?: Issuance Of Sixth Amendment Warrants as reported by Biodesix, Inc. Common Stock.

Ask your AI about Biodesix, Inc.'s issuance of sixth amendment warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk